Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
A New Approach to Autoimmunity
Using Multi-Omic Technology to Reclassify and Improve Treatment for Autoimmune Disease
Toward a Universal Flu Vaccine
New Candidate Fights Back against the Flu’s Efforts to Undermine the Human Immune System
James Vasta Ph.D.
James Vasta, Ph.D., is a research scientist at Promega.